How comparable are patient outcomes in the 'real-world' with populations studied in pivotal AML trials?

MLA

Ing Soo Tiong, et al. “How Comparable Are Patient Outcomes in the ‘Real-World’ with Populations Studied in Pivotal AML Trials?” Blood Cancer Journal, vol. 14, no. 1, Mar. 2024, pp. 1–11. EBSCOhost, https://doi.org/10.1038/s41408-024-00996-x.

APA

Ing Soo Tiong, Meaghan Wall, Ashish Bajel, Akash Kalro, Shaun Fleming, Andrew W. Roberts, Nisha Thiagarajah, Chong Chyn Chua, Maya Latimer, David Yeung, Paula Marlton, Amanda Johnston, Anoop Enjeti, Chun Yew Fong, Gavin Cull, Stephen Larsen, Glen Kennedy, Anthony Schwarer, David Kipp, … Australasian Leukaemia and Lymphoma Group (ALLG). (2024). How comparable are patient outcomes in the “real-world” with populations studied in pivotal AML trials? Blood Cancer Journal, 14(1), 1–11. https://doi.org/10.1038/s41408-024-00996-x

Chicago

Ing Soo Tiong, Meaghan Wall, Ashish Bajel, Akash Kalro, Shaun Fleming, Andrew W. Roberts, Nisha Thiagarajah, et al. 2024. “How Comparable Are Patient Outcomes in the ‘Real-World’ with Populations Studied in Pivotal AML Trials?” Blood Cancer Journal 14 (1): 1–11. doi:10.1038/s41408-024-00996-x.